miRNA expression profiling of mycosis fungoides
- 24 February 2011
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 5 (3) , 273-280
Abstract
MicroRNAs (miRNAs) are small RNA species that regulate gene expression post‐transcriptionally and are aberrantly expressed in many malignancies including lymphoma. However, the role of miRNAs in the pathogenesis of T‐cell lymphoid malignancies is poorly understood. Previously we examined the miRNA profile of Sézary syndrome (Sz), a leukemia of skin‐homing memory T cells. In this study we determined the complete miRNome of mycosis fungoides (MF), the most common type of cutaneous T cell lymphoma. The miRNA profile of skin biopsies from 19 patients with tumor stage MF and 12 patients with benign inflammatory dermatoses (eczema and lichen planus) were compared by microarray analysis. We identified 49 miRNAs that are differentially expressed in tumor stage MF compared to benign inflammatory dermatoses using ANOVA analysis (P < 0.05, Benjamini–Hochberg corrected). The majority of the differentially expressed miRNAs (30/49) were up‐regulated in tumor stage MF. The most significant differentially expressed were miR‐155 and miR‐92a (both up‐regulated in tumor stage MF), while miR‐93 showed the highest up‐regulation in tumor stage MF with a fold difference of 5.8. Differential expression of a selection of these miRNAs was validated by miRNA‐Q‐PCR on additional test groups (tumors and controls). None of the miRNAs up‐regulated in tumor stage MF was previously shown to be up‐regulated in Sz, and only 2 of the 19 miRNAs down‐regulated in tumor stage MF were also down‐regulated in Sz. Taken together this report is the first describing the miRNA signature of tumor stage MF.Keywords
Funding Information
- Netherlands Organization for Scientific Research
- the Fondation René Touraine
- Leukaemia and Lymphoma Research
- Julian Starmer-Smith Memorial Fund
This publication has 30 references indexed in Scilit:
- MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8Oncogene, 2010
- Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis FungoidesJournal of Investigative Dermatology, 2010
- Physiological and pathological roles for microRNAs in the immune systemNature Reviews Immunology, 2010
- The microRNA-17~92 cluster: Still a miRacle?Cell Cycle, 2009
- miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1Molecular Cancer Research, 2009
- Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disordersJournal of Dermatological Science, 2008
- Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3Leukemia, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression AnalysisCancer Research, 2004
- Normalization of cDNA microarray dataMethods, 2003